According to Nevro 's latest financial reports the company's current earnings (TTM) are -$89.85 M. In 2022 the company made an earning of $10.69 M an increase over its 2021 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$89.85 M | -939.99% |
2022 | $10.69 M | -109.63% |
2021 | -$0.12 B | 83.93% |
2020 | -$60.4 M | -33.75% |
2019 | -$91.16 M | 139.66% |
2018 | -$38.04 M | 50.06% |
2017 | -$25.35 M | 6.68% |
2016 | -$23.77 M | -62.6% |
2015 | -$63.54 M | 118.31% |
2014 | -$29.11 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | $6.29 B | -7,109.85% | ๐บ๐ธ USA |
Abiomed ABMD | $0.34 B | -479.73% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | $1.76 B | -2,066.50% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | -$0.15 B | 55.88% | ๐บ๐ธ USA |